Diabetic Kidney Disease

Digital Education Hubs

CME Activities
DKD News Digest
Expert Highlights and Perspectives
Rajiv Agarwal, MD

Interpreting New Evidence with Novel Non-Steroidal MRA's for Cardiorenal Risk Reduction

Rajiv Agarwal,
MD

George L. Bakris,
MD

Bertram Pitt,
MD

Watch the experts share some highlights including:

New and ongoing studies with novel non-steroidal MRAs in addressing cardiorenal risk, including in patients with heart failure and in those with non-diabetic kidney disease. 

Janet B. McGill, MD

Interview #1

Evaluating the Risk For DKD Progression

Janet McGill,
MD

George L. Bakris,
MD

Watch the experts share some highlights including:

  • Early recognition and screening for DKD
  • Monitoring kidney function
  • Risk factors for DKD progression
Rajiv Agarwal, MD
Interview #2

The Rationale For Non-Steroidal MRAS In DKD

Rajiv Agarwal,
MD

George L. Bakris,
MD

Watch the experts share some highlights including:

  • Differentiating between steroidal and non-steroidal MRAs
  • Adverse events and limitations with steroidal MRAs in DKD
  • Advantages of finerenone in DKD
  • The overview of kidney results of the FIDELIO trial
Rajiv Agarwal, MD

Interview #3

The Cardiovascular Benefits of Finerenone

Rajiv Agarwal,
MD

George L. Bakris,
MD

Watch the experts share some highlights including:

  • The interplay between the kidney and heart
  • CVD benefits of finerenone: analysis from the FIDELIO trial and ongoing CVD studies with finere none
  • How does finerenone fit within the context of SGLT-2is

Interview #4

Finerenone: Putting the Data Into Context

George L. Bakris,
MD

Watch the experts share some highlights including:

  • Finerenone in the context of existing treatments
  • Clinical pearls for incorporating finerenone to the DKD treatment armamentarium in the near future
Additional Resources

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.